Remedent, Inc.

REMI · OTC
Analyze with AI
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Activities
Net Income-$274-$330$146$10
Dep. & Amort.$20$25$28$36
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$38$182-$402-$59
Other Non-Cash$86$69$59$14
Operating Cash Flow-$131-$53-$169$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$68-$15$265-$39
Net Chg. in Cash-$62-$68$96-$37
Supplemental Information
Beg. Cash$105$174$78$115
End Cash$43$105$174$78
Free Cash Flow-$131-$53-$169$2